Tag Archives: Galapagos NV

Cowen & Co. Assigns a Buy Rating on Galapagos NV

Cowen & Co. analyst Phil Nadeau assigned a Buy rating to Galapagos NV (NASDAQ: GLPG) yesterday. The company’s shares opened today at $101.83. According to TipRanks.com, Nadeau is a 5-star analyst with an average return of 15.1% and a 57.9%

Galapagos NV Receives a Buy from BTIG

BTIG analyst Dane Leone reiterated a Buy rating on Galapagos NV (NASDAQ: GLPG) on April 27 and set a price target of $118. The company’s shares closed on Friday at $90.60. Leone noted: “Before-mkt-open on Thursday, Galapagos hosted their 1Q18

Galapagos NV Gets a Buy Rating from BTIG

In a report released yesterday, Dane Leone from BTIG reiterated a Buy rating on Galapagos NV (NASDAQ: GLPG), with a price target of $118. The company’s shares closed yesterday at $114.98, close to its 52-week high of $121.09. According to

Stifel Nicolaus Believes Galapagos NV (NASDAQ: GLPG) Still Has Room to Grow

Stifel Nicolaus analyst Adam Walsh reiterated a Buy rating on Galapagos NV (NASDAQ: GLPG) on October 27 and set a price target of $120. The company’s shares closed on Friday at $97.17, close to its 52-week high of $104.12. According

Analysts Offer Insights on Healthcare Companies: Galapagos NV (NASDAQ: GLPG) and Aurinia Pharmaceuticals (NASDAQ: AUPH)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Galapagos NV (NASDAQ: GLPG) and Aurinia Pharmaceuticals (NASDAQ: AUPH) with bullish sentiments. Galapagos NV (NASDAQ: GLPG) In a report released today, Adam

Galapagos NV Receives a Buy from Cowen & Co.

In a report released today, Phil Nadeau from Cowen & Co. reiterated a Buy rating on Galapagos NV (NASDAQ: GLPG). The company’s shares opened today at $83.24. According to TipRanks.com, Nadeau is a 5-star analyst with an average return of